US 8084415
Uteroglobin in the treatment of IGA mediated nephropathy
granted A61KA61K38/1709A61P
Quick answer
US patent 8084415 (Uteroglobin in the treatment of IGA mediated nephropathy) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K38/1709, A61P, A61P11/00, A61P29/00